Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Mallinckrodt Hospital Products Inc. recalls Acthar Gel (repository corticotropin injection) 400 USP units/5mL (80 USP units/mL)

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
cGMP deviations: Temperature excursion due to shipping delay from manufacturer to distributor. Affected distributor has been notified.
Products
  • Acthar Gel (repository corticotropin injection) 400 USP units/5mL (80 USP units/mL)
Where it was sold

USA nationwide

Nationwide

Units affected
8 vials involved in recall (16,479 vials distributed)
About this recall
Acthar Gel (repository corticotropin injection) 400 USP units/5mL (80 USP units/mL), 5mL multiple-dose vial, Rx only, Mfd. for: Mallinckrodt ARD LLC, Bridgewater, NJ 08807, NDC 63004-8710-1